The Biomedical Advanced Research and Development Authority (BARDA) and the Office of Acquisitions Management, Contracts and Grants (AMCG) will host an Industry Day event November 12-14, 2013 in Washington D.C.
The first two days of the conference will provide an overview of Project BioShield and BARDA’s priorities for product development and manufacturing for all threats going forward from Fiscal Year 2014, as well as the range of agreements that BARDA and AMCG use to work with the private sector.
Day three is for one-on-one meetings between conference attendees and BARDA Program Staff and/or AMCG Contracting Officers to discuss their specific interest and questions about working with BARDA. Requests for such meetings must be submitted at the time of registration for the conference.
BARDA supports the advanced research & development, manufacturing, acquisition, and stockpiling of medical countermeasures (drugs, biological therapeutics, vaccines, diagnostics, and non-pharmaceutical countermeasures) against chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging infectious diseases. BARDA oversees all procurements made under Project BioShield, an act passed by Congress in 2004 to encourage private sector involvement in these activities.
Further details are available at the Medical Countermeasures website.
